Literature DB >> 1954082

The effect of metoclopramide on mefloquine pharmacokinetics.

K Na Bangchang, J Karbwang, D Bunnag, T Harinasuta, D J Back.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1954082      PMCID： PMC1368648          DOI： 10.1111/j.1365-2125.1991.tb03969.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  Determination of mefloquine in biological fluids using high performance liquid chromatography.

Authors:  J Karbwang; P Molunto; K Na Bangchang; D Bunnag
Journal:  Southeast Asian J Trop Med Public Health       Date:  1989-03       Impact factor: 0.267

Review 2.  Drug treatment and prevention of malaria.

Authors:  N J White
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Neurologic reactions after a therapeutic dose of mefloquine.

Authors:  L C Patchen; C C Campbell; S B Williams
Journal:  N Engl J Med       Date:  1989-11-16       Impact factor: 91.245

4.  Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.

Authors:  T Harinasuta; D Bunnag; S Vanijanond; P Charoenlarp; P Suntharasmai; S Chitamas; U K Sheth; W H Wernsdorfer
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

5.  Single-dose therapy of falciparum malaria with mefloquine or pyrimethamine-sulfadoxine.

Authors:  E B Doberstyn; P Phintuyothin; S Noeypatimanondh; C Teerakiartkamjorn
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

6.  A phase-III clinical trial of mefloquine in children with chloroquine-resistant falciparum malaria in Thailand.

Authors:  T Chongsuphajaisiddhi; A Sabchareon; P Chantavanich; V Singhasivanon; P Attanath; W H Wernsdorfer; U K Sheth
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

Review 7.  Metoclopramide: pharmacology and clinical application.

Authors:  R Albibi; R W McCallum
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

8.  Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria.

Authors:  T Harinasuta; D Bunnag; R Lasserre; R Leimer; S Vinijanont
Journal:  Lancet       Date:  1985-04-20       Impact factor: 79.321

Review 9.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

10.  A double-blind comparative clinical trial of mefloquine and chloroquine in symptomatic falciparum malaria.

Authors:  J M Kofi Ekue; A M Ulrich; J Rwabwogo-Atenyi; U K Sheth
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408
View more
  2 in total

1.  Pharmacokinetics of quinine in patients with chronic renal failure.

Authors:  P Rimchala; J Karbwang; K Sukontason; V Banmairuroi; P Molunto; K Na-Bangchang
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

Review 2.  Pharmacokinetic drug interactions with gastrointestinal motility modifying agents.

Authors:  J M Greiff; D Rowbotham
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.